Page 1 of Clinical Trials for Drug Botulinum Toxin Type A, 316 Total Matches
- 1WithdrawnLast Updated: February 23, 2011Condition(s): Neurogenic Detrusor Overactivity
- 2Not yet recruitingLast Updated: March 10, 2011Condition(s): Muscle Spasticity
- 3CompletedLast Updated: September 1, 2011Condition(s): Glabellar Rhytides; Frown Lines Between the Eyebrows
- 4CompletedLast Updated: June 24, 2011Condition(s): Lateral Canthal Lines; Crow's Feet; Facial Wrinkles
- 5RecruitingLast Updated: December 5, 2011Condition(s): Peyronie's Disease
- 6RecruitingLast Updated: February 10, 2011Condition(s): Chronic Prostatitis With Chronic Pelvic Pain Syndrome; Prostatitis
- 7Not yet recruitingLast Updated: August 24, 2010Condition(s): Wrinkles in the Glabellar Region Facial.
- 8CompletedTrial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of SpasticityLast Updated: July 6, 2011Condition(s): Spasticity
- 9RecruitingLast Updated: August 22, 2011Condition(s): Stroke With Hemiparesis
- 10CompletedLast Updated: November 22, 2011Condition(s): Wrinkles
- 11CompletedComparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential BlepharospasmLast Updated: May 21, 2008Condition(s): Blepharospasm
- 12CompletedLast Updated: November 8, 2010Condition(s): Skin Aging
- 13RecruitingLast Updated: June 23, 2011Condition(s): Bruxism
- 14CompletedLast Updated: December 15, 2011Condition(s): Neuromuscular Agents; Botulinum Toxin Type A; Hyperhidrosis; Sweat Gland Disease; Skin Disease; Sweating
- 15CompletedLast Updated: September 1, 2011Condition(s): Glabellar Rhytides
- 16Active, not recruitingLast Updated: August 18, 2011Condition(s): Mumps
- 17CompletedLast Updated: September 1, 2011Condition(s): Glabellar Rhytides
- 18CompletedLast Updated: December 22, 2005Condition(s): Migraine Without Aura Prophylaxis
- 19CompletedLast Updated: January 23, 2012Condition(s): Glabellar Frown Lines
- 20CompletedLast Updated: March 31, 2009Condition(s): Healthy
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Botulinum+Toxin+Type+A
